Adline Chem Lab (524604.BO) Stock Price

Adline Chem Lab Price

CLOSED
12.60
​
Market closed

For Adline Chem Lab, the net margin of 97.4% is up versus -20.3% a few years ago.

Adline Chem Lab stock price

Access this data via the Eulerpool API

Adline Chem Lab business model & stock analysis

Adline Chem Lab Ltd. engages in the manufacture of pharmaceutical products. The company is headquartered in Ahmedabad, Gujarat. The firm is operating in one segment: pharmaceutical products. The firm's products for the domestic market include anti-infectives, bone health, gastroenterology care, hemostatic, multi-vitamins, pediatric care, pain and inflammation, pregnancy and reproductive care, respiratory care and hepatocare. The firm's products for the international market include tablets, capsules and injections. The firm's veterinary products include B Complex Liver Extract With Vitamin B12 Inection, Chlorpheniramine Injection IP, Triflupromazine Hydrochloride Injection IP, Triamcinolone Acctonide Injection IP, Triamcinolone Acetonide IP and Tetracyclin-bolus Tablets. The Company’s educational supplements include Demo-Dose Dyaz, Demo-dose colac, Demo-Dose Dilat and Demo-Eose eryth.

Frequently asked questions about Adline Chem Lab

Converted at the current exchange rate, the Adline Chem Lab share trades at 0.12 EUR (12.60 INR).

The revenue cannot currently be calculated for Adline Chem Lab.

The profit cannot currently be calculated for Adline Chem Lab.

The P/E ratio cannot be calculated for Adline Chem Lab at the moment.

The P/S cannot be calculated for Adline Chem Lab currently.

The Eulerpool Quality Score for Adline Chem Lab is 2/10.

The ISIN of Adline Chem Lab is INE276T01018. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Adline Chem Lab is 524604.BO. The ticker symbol is used to trade Adline Chem Lab shares on the stock exchange.

Fair ValueTerminal
12.98 INR
Over-/UndervaluationTerminal
Fairly valued
Sector
—
Industry
Other
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Currency
INR
Initial public offering
Jan 20, 1993
ISIN
INE276T01018
Cusip
Y4549K124
Market capitalization
73.71 M INRMicro Cap
52-Week Range
Revenue growth (10Y) > 5%
Revenue growth (3Y) > 5 %
EBIT growth (10Y) > 5%
EBIT growth (3Y) > 5 %
Net debt < 4x EBIT
Profitable since 10Y+
EBIT Drawdown (10Y) < 50%
Return on Equity (ROE) > 15%
ROCE > 15%
Return Expectation > 10%
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
2.78
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
1,806.58 %
Gross Margin
—
EBIT Margin
—
Net Margin
—
EPS (Earnings Per Share)
-0.23 INR
Net Debt / EBIT
—
Debt/Equity
-0.85
Last updated Oct 5, 2026, 5:42 PM

Adline Chem Lab Peer Group

Adline Chem Lab FIGI

ADLINE:IN · BBG000DK8MY6ADLINE:IB · BBG000DK8N92

All fundamentals and in-depth analysis of Adline Chem Lab

Our stock analysis for Adline Chem Lab stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Adline Chem Lab. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.